A Standardised, Generic, Validated Approach to Stratify the Magnitude of Clinical Benefit that can be Anticipated from Anti-Cancer Therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

6 September 2016: Two corrections to the original article have been published. View the corrigendum on Annals of Oncology